%0 Journal Article
%A Baum, Philip
%A Cardoso, Rafael
%A Lenzi, Jacopo
%A Damhuis, Ronald A M
%A Verhagen, Ad F T M
%A De Gendt, Cindy
%A Peacock, Hanna
%A De Leyn, Paul
%A Christensen, Niels L
%A Innos, Kaire
%A Oselin, Kersti
%A Zadnik, Vesna
%A Zagarv, Tina
%A Brenner, Hermann
%A Winter, Hauke
%T An International Registry Study of Early-Stage NSCLC treatment variations (LUCAEUROPE) in Europe and the USA highlighting variations.
%J European journal of cancer
%V 209
%@ 0014-2964
%C Amsterdam [u.a.]
%I Elsevier
%M DKFZ-2024-01527
%P 114233
%D 2024
%X Harmonized European NSCLC incidence, treatment approach, and survival based on national tumor registries are unclear.Surgery has the potential to cure NSCLC and significantly prolong survival. This large-scale international study aimed to investigate treatment variations in Europe and the USA, as well as the determinants for its utilization.The retrospective cohort study analyzed data from six European national population-based cancer registries (Belgium, Denmark, Estonia, Germany, the Netherlands, and Slovenia) and the US SEER database from 2010-2015.The study computed cancer incidence, survival, and age-standardized proportions of the use of various therapies. Multivariable logistic regression models were used to assess associations between resection and demographic and clinical parameters. A total of 428,107 records were analyzed. Among all countries, Estonia had the highest surgical resection rate (79.3 
%K Incidence (Other)
%K Lung cancer (Other)
%K Radiotherapy (Other)
%K SBRT (Other)
%K Surgery (Other)
%K Survival (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:39053290
%R 10.1016/j.ejca.2024.114233
%U https://inrepo02.dkfz.de/record/291915